Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q3FY24 of
Marksans Pharma Ltd Q3FY24; 34% rise in Profits
Categories
pharmaceuticals
GMM Pfaudler Ltd Q3FY24; 63% rise in Profits
GMM Pfaudler manufactures corrosion resistant glass-lined equipments . It is a leading supplier of process equipments to the pharmaceutical and chemical industries
Laurus Labs Ltd Q3FY24; 89% fall in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients
Natco Pharma Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Natco Pharma Ltd (NATCOPHARM) Q3 FY24 Earnings Concall Financial Performance Recorded total revenue of INR795.6 crores in Q3 FY'24,
Strides Pharma Science Ltd Q3FY24; 20% rise in Revenue
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Jubilant Ingrevia Ltd Q3FY24; 58% fall in Profits
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our
Divi’s Laboratories Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY24 Earnings Concall Growth and Performance Witnessed a steady 3Q driven by expanding market
Zydus Lifesciences Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q3 FY24 Earnings Concall India Formulations Double-digit growth led by volume expansion and new launches.
Jubilant Pharmova Ltd Q3FY24; 8% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Glenmark Pharmaceuticals Ltd Q3FY24; 228% rise in Profits
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
Cipla Limited Q3 FY24 Earnings Conference Call Insights
Key highlights from Cipla Limited (CIPLA) Q3 FY24 Earnings Concall Financial Performance Revenue grew 14% to INR 6,544 crores. EBITDA margin expanded
Caplin Point Laboratories: Navigating Successes and Facing Challenges in Pharmaceutical Expansion.
Company Description: Caplin Point Laboratories, established in 1990, has evolved into a leading pharmaceutical company with a diverse product range, specializing in
Glenmark Life Sciences Ltd Q2FY24; 11% rise in Profits
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Alembic Pharmaceuticals Ltd Q2FY24; 3% rise in Profits
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has
Zydus Lifesciences Ltd Q2FY24; 53% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Alkem Laboratories Ltd Q2FY24; 77% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Aarti Pharmalabs Ltd Q2FY24; 2% rise in Profits
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues for Q2FY24
Glenmark Pharmaceuticals Ltd Q2FY24; 6% rise in Revenue
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
Tarsons Products Ltd Q2FY24; 38% fall in Profits
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'
Biocon Ltd Q2FY24; 111% rise in Profits
Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q2FY24
Solara Active Pharma Sciences Ltd Q2FY24; 26% rise in Revenue
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.